[Metastatic medullary thyroid carcinoma in a child with multiple endocrine neoplasia 2B. Efficiency of medium-term treatment with vandetanib without thyroid surgery].

MLA

Segura, D., et al. “[Metastatic Medullary Thyroid Carcinoma in a Child with Multiple Endocrine Neoplasia 2B. Efficiency of Medium-Term Treatment with Vandetanib without Thyroid Surgery].” Archives de Pediatrie : Organe Officiel de La Societe Francaise de Pediatrie, vol. 23, no. 8, Aug. 2016, pp. 840–44. EBSCOhost, https://doi.org/10.1016/j.arcped.2016.05.007.

APA

Segura, D., Dupuis, C., Chabre, O., Piolat, C., Durand, C., & Plantaz, D. (2016). [Metastatic medullary thyroid carcinoma in a child with multiple endocrine neoplasia 2B. Efficiency of medium-term treatment with vandetanib without thyroid surgery]. Archives de Pediatrie : Organe Officiel de La Societe Francaise de Pediatrie, 23(8), 840–844. https://doi.org/10.1016/j.arcped.2016.05.007

Chicago

Segura, D, C Dupuis, O Chabre, C Piolat, C Durand, and D Plantaz. 2016. “[Metastatic Medullary Thyroid Carcinoma in a Child with Multiple Endocrine Neoplasia 2B. Efficiency of Medium-Term Treatment with Vandetanib without Thyroid Surgery].” Archives de Pediatrie : Organe Officiel de La Societe Francaise de Pediatrie 23 (8): 840–44. doi:10.1016/j.arcped.2016.05.007.